Lymphact Lymphocyte Act is a company that provides Biotechnology, Lymphocyte, Viral disease and more. Lymphact Lymphocyte Act is headquartered in PT EV. Lymphact Lymphocyte Act was founded in 2013. Lymphact Lymphocyte Act has a total of 23 patents
Lymphact Lymphocyte Act is in the industry of:Research and Development in the Physical, Engineering, and Life SciencesPharmaceutical and Medicine Manufacturing
What technical fields has Lymphact Lymphocyte Act researched?
Lymphact - Lymphocyte Activation Technologies SA provides biotechnology solutions. It develops treatments for cancer and chronic viral diseases. The firm...